Effect of cis-diammine dichloroplatinum on vascular endothelial growth factor expression in uterine cervical carcinoma

European Journal of Gynaecological Oncology

Volumn 25, Issue 1, 2004, Pages 33-39

  Miyahara, Y ^a   Yoshida, S ^a   Motoyama, S ^a   Tateiwa, Y ^a   Hamana, S ^a   Maruo, T ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CaSki cells; CDDP; Percutaneous pelvic perfusion extracorporeal chemofiltration (PPPEC); RT PCR; Uterine cervical carcinoma; VEGF

Indexed keywords

CD34 ANTIGEN; CISPLATIN; MESSENGER RNA; MONOCLONAL ANTIBODY; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; UTERINE CERVIX CARCINOMA;

ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0842263680     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Folkman J.: "The role of angiogenesis in tumor growth". Semin. Cancer Biol., 1992, 3, 65.
2. Folkman J.: "What is the evidence that tumors are angiogenesis dependent?". J. Natl. Cancer Inst., 1990, 82, 4.
3. Weidner N., Semple J.P., Welch W.R., Folkman J.: "Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma". N. Engl. J. Med., 1991, 324, 1.
4. Liotta L., Kleinerman J., Saidel G.M.: "Quantitative relationships of intravascular tumors cells, tumor vessels, and plumonary metastases following tumor implication". Cancer Res., 1974, 34, 997.
5. Kaku T., Kamura T., Kinukawa N., Kawauchi S., Tsuneyoshi M., Nakano H. et al.: "Angiogenesis in endometrial carcinoma". Cancer, 1997, 80, 741.
6. Mattern J., Stammler G., Koomagi R., Wallwiener D., Kaufmann M., Volm M.: "Association of vascular endothelial growth factor expression with tumor cell proliferation in ovarian carcinoma". Anticancer Res., 1997. 17, 621.
7. Dirix L.Y., Vermeulen P.B., Pawinski A., Martin M., Van Oosterom A.T.: "Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients". Br. J. Cancer, 1997, 76, 238.
8. Stafl A., Mattingly R.F.: "Angiogenesis of cervical neoplasia". Am. J. Obstet. Gynecol., 1975, 121, 845.
9. Chomette G., Auriol M., Tranbaloc P., Blondon J.: "Intraepithelial neoplasm of the uterine cervix and angiogenesis; morphologic study". Arch. Anat. Cytol. Pathol., 1989, 37, 73.
10. Smith-McCune K.K., Weidner N.: "Demonstration and characterization of the angiogenic properties of cervical dysplasia". Cancer Res., 1994, 54, 800.
11. Sillman F., Boyce J., Fruchter R.: "The significance of atypical vessels and neovascularization in cervical neoplasia". Am. J. Obstet. Gynecol., 1981, 139, 154.
12. Loncaster J.A., Cooper R.A., Logue J.P., Davidson S.E., Hunter R.D., West C.M.: "Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix". Br. J. Cancer, 2000, 83, 620.
13. Shishido T., Yasoshima T., Denno T., Mukaiya M., Sato N., Hirata K.: "Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin". Jpn. J. Cancer Res., 1998, 89, 963.
14. Emoto M., Ishiguro M., Iwasaki H., Kikuchi M., Kawarabayashi T.: "TNP-470 inhibits growth and production of vascular endothelial growth factor of uterine carcinosarcoma cells". Anticancer Res., 2000, 20, 601.
15. Santin A.D., Hermonat P.L., Ravaggi A., Pecorelli S., Cannon M.J., Parham G.P.: "Secretion of vascular endothelial growth factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix". Obstet. Gynecol., 1999, 94, 78.
16. Dinh T.V., Hannigan E.V., Smith E.R., Hove M.J., Chopra V., To T.: "Tumor angiogenesis as a predictor of recurrence in stage Ib squamous cell carcinoma of the cervix". Obstet. Gynecol., 1996, 87, 751.
17. Hamana S., Motoyama S., Yoshida S., Miyahara Y., Tateiwa Y., Maruo T.: "Super high-dose intraarterial cisplatin infusion under percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma. I. Analysis for pharmacokinetics, tumor response, and toxicity of platinum". Am. J. Clin. Oncol., 2001, 24, 241.
18. Motoyama S., Hamana S., Miyahara Y., Tateiwa Y., Yoshida S., Maruo T.: "Super high-dose intraarterial cisplatin infusion under percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma. II. Its impact on clinical response and subsequent surgery". Am. J. Clin. Oncol., 2001, 24, 247.
19. Ishikawa H., Kikkawa F., Tamakoshi K., Matsuzawa K., Suganuma N., Tomoda Y. et al.: "Distribution of platinum in human gynecologic tissue and lymph nodes after intravenous and intraarterial neoadjvant chemotherapy". Anticancer Res., 1996, 16, 3849.
20. Bradford M.: "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding". Anal. Biochem., 1976, 72, 248.
21. Maruo T., Mochizuki M.: "Immunohistochemical localization of epidermal growth factor receptor and myc oncogene product in human placenta: implication for trophblast proliferation and differentiation". Am. J. Obstet. Gynecol., 1987, 156, 721.
22. Guidi A.J., Abu-Jawdeh G., Berse B., Tognazzi K., Dvorak H.F., Brown L.F. et al.: "Vascular permeability factor (Vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia". J. Natl. Cancer Inst., 1995, 87, 1237.
23. Obermair A., Wanner C., Bilgi S., Speiser P., Leodolter S., Gitsch G. et al.: "Tumor angiogenesis in stage lb cervical cancer: Correlation of microvessel density with survival". Am. J. Obstet. Gynecol., 1998, 178, 314.
24. Dellas A., Moch H., Schultheiss E., Feichter G., Gudat F., Torhorst J.: "Angiogenesis in cervical neoplasia: Microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations". Gynecol. Oncol., 1997, 67, 27.
25. Lissoni P., Fugamalli E., Malugani F., Ardizzoia A., Tancini G., Gardani G.S. et al.: "Chemotherapy and angiogenesis in advanced cancer: vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancer". Int. J. Biol. Markers, 2000, 15, 308.
26. Kohno Y., Iwanari O., Kitao M.: "Prognostic importance of histologic vascular density in cervical cancer treated with hypertensitive intraarterial chemotherapy". Cancer, 1993, 72, 2394.
27. Katoh O., Takahashi T., Oguri T., Kobayashi M., Hirata S., Watanabe H.: "Vasucular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor". Cancer Res., 1998, 58, 5565.
28. Fernandez A., Udagawa T., Schwesinger C., Beecken W., McDonnell T., D'Amato R.: "Angiogenetic potential of prostate carcinoma cells overexpressing bcl-2". J. Natl. Cancer Inst., 2001, 93, 208.
29. Foekens J.A., Peters H.A., Geurts-Moespot A., Sweep C.G., Klijn J.G.: "High tumor levels of vascular endothelial factor predict poor response to systemic therapy in advanced breast cancer". Cancer Res., 2001, 61, 5407.
30. Yanase T., Tamura M., Fujita K., Kodama S., Tanaka K.: "Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell line in vitro and in vivo". Cancer Res., 1993, 53, 2566.
31. Kusaka M., Sudo K., Matsutani E., Ingber D., Folkman J.: "Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470". Br. J. Cancer, 1994, 69, 212.
32. Yamamoto T., Sudo K., Fujita T.: "Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470". Anticancer Res., 1994, 14, 1.
33. Shishido T., Yasoshima T., Denno R.: "Inhibition of liver metastasis of human gastric carcinoma by angiogenesis inhibitor, TNP-470". Cancer Res., 1996, 87, 958.
34. Kato T., Sato K., Kakinuma H., Matsuda Y.: "Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(Chloroacetyl-carbamoyl) fumagillol (TNP-470) and cytotoxic agents in mice". Cancer Res., 1994, 54, 5143.
35. Yamaoka M., Yamamoto T., Ikeyama S., Sudo K., Fujita T.: "Angiogenesis inhibitor TNP-470 potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell line". Cancer Res., 1993, 53, 5233.